Nature of fatty acids in high fat diets differentially delineates obesity-linked metabolic syndrome components in male and female C57BL/6J mice

Diabetology and Metabolic Syndrome

Volumn 3, Issue 1, 2011, Pages

  El Akoum, Souhad ^a,b   Lamontagne, Vikie ^a,b   Cloutier, Isabelle ^a   Tanguay, Jean François ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adipocyte; Adipokines; Diabetes; High Fat Diet; Metabolic disorders; Obesity; Type 2 Diabetes

Indexed keywords

ADIPONECTIN; ARACHIDIC ACID; ARACHIDONIC ACID; BEHENIC ACID; CHOLESTEROL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FATTY ACID; GLUCOSE; INSULIN; LEPTIN; LIGNOCERIC ACID; LINOLEIC ACID; MESSENGER RNA; MONOUNSATURATED FATTY ACID; MYRISTIC ACID; OLEIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; POLYUNSATURATED FATTY ACID; RESISTIN; STEARIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT DISTRIBUTION; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; FAT INTAKE; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; INTRAABDOMINAL FAT; LIPID DIET; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PEROXISOME; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTEMIC CIRCULATION; WEIGHT GAIN;

EID: 83355164463     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-3-34     Document Type: Article

References (48)

1. Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation. Schuster DP, Diabetes Metab Syndr Obes 3 253 262
2. Digging deeper into obesity. Ahima RS, J Clin Invest 121 2076 2079
3. Adiponectin, a key adipokine in obesity related liver diseases. Buechler C, Wanninger J, Neumeier M, World J Gastroenterol 17 2801 2811
4. Human resistin: found in translation from mouse to man. Schwartz DR, Lazar MA, Trends Endocrinol Metab 22 259 265
5. Leptin receptor signaling: pathways to leptin resistance. Wauman J, Tavernier J, Front Biosci 17 2771 2793
6. The secretory function of adipocytes in the physiology of white adipose tissue. Wang P, Mariman E, Renes J, Keijer J, J Cell Physiol 2008 216 3 13 10.1002/jcp.21386 18264975 (Pubitemid 351813090)
7. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Unger RH, Clark GO, Scherer PE, Orci L, Biochim Biophys Acta 1801 209 214
8. Adipose tissue: the link between obesity and cardiovascular disease. Declercq V, Taylor C, Zahradka P, Cardiovasc Hematol Disord Drug Targets 2008 8 228 237 10.2174/187152908785849080 18781935
9. Update on obesity. Bessesen DH, J Clin Endocrinol Metab 2008 93 2027 2034 10.1210/jc.2008-0520 18539769 (Pubitemid 351831511)
10. Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. Mirza MS, ISRN Gastroenterol 2011 592404
11. Dietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet. Shertzer HG, Woods SE, Krishan M, Genter MB, Pearson KJ, J Nutr 141 582 587
12. Sex differences during the course of diet-induced obesity in mice: adipose tissue expandability and glycemic control. Medrikova D, Jilkova ZM, Bardova K, Janovska P, Rossmeisl M, Kopecky J, Int J Obes (Lond)
13. Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Macotela Y, Boucher J, Tran TT, Kahn CR, Diabetes 2009 58 803 812 10.2337/db08-1054 19136652
14. Could the quality of dietary fat, and not just its quantity, be related to risk of obesity? Moussavi N, Gavino V, Receveur O, Obesity (Silver Spring) 2008 16 7 15 10.1038/oby.2007.14 (Pubitemid 351271943)
15. Saturated fatty acids and insulin resistance. Funaki M, J Med Invest 2009 56 88 92 10.2152/jmi.56.88 19763019
16. 17beta-Estradiol inhibition of PPARgamma-induced adipogenesis and adipocyte-specific gene expression. Jeong S, Yoon M, Acta Pharmacol Sin 32 230 238
17. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
18. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y, J Am Soc Nephrol 2002 13 1894 1900 10.1097/01.ASN.0000019900.87535.43 12089386 (Pubitemid 34700615)
19. High levels of industrially produced trans fat in popular fast foods. Stender S, Dyerberg J, Astrup A, N Engl J Med 2006 354 1650 1652 10.1056/NEJMc052959 16611965
20. Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Paniagua JA, Gallego de la Sacristana A, Romero I, Vidal-Puig A, Latre JM, Sanchez E, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F, Diabetes Care 2007 30 1717 1723 10.2337/dc06-2220 17384344 (Pubitemid 47036342)
21. The influence of the type of dietary fat on postprandial fat oxidation rates: monounsaturated (olive oil) vs saturated fat (cream). Piers LS, Walker KZ, Stoney RM, Soares MJ, O'Dea K, Int J Obes Relat Metab Disord 2002 26 814 821 12037652 (Pubitemid 34620874)
22. Android fat depot is more closely associated with metabolic syndrome than abdominal visceral fat in elderly people. Kang SM, Yoon JW, Ahn HY, Kim SY, Lee KH, Shin H, Choi SH, Park KS, Jang HC, Lim S, PLoS One 6 27694
23. The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2. Saad F, Gooren LJ, J Obes 2011
24. Effects of dietary fatty acids on insulin sensitivity and secretion. Manco M, Calvani M, Mingrone G, Diabetes Obes Metab 2004 6 402 413 10.1111/j.1462-8902.2004.00356.x 15479216 (Pubitemid 39409791)
25. The hormone resistin links obesity to diabetes. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA, Nature 2001 409 307 312 10.1038/35053000 11201732 (Pubitemid 32151228)
26. Effects of metformin and oleic acid on adipocyte expression of resistin. Rea R, Donnelly R, Diabetes Obes Metab 2006 8 105 109 10.1111/j.1463-1326.2005. 00477.x 16367888
27. Apoptosis, Mastocytosis, and Diminished Adipocytokine Gene Expression Accompany Reduced Epididymal Fat Mass in Long-Standing Diet-Induced Obese Mice. Altintas MM, Rossetti MM, Nayer B, Puig A, Zagallo P, Ortega LM, Johnson KB, McNamara G, Reiser J, Mendez AJ, Nayer A, Lipids Health Dis 10 198
28. Estrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Stubbins RE, Najjar K, Holcomb VB, Hong J, Nunez NP, Diabetes Obes Metab
29. Storage of circulating free fatty acid in adipose tissue of postabsorptive humans: quantitative measures and implications for body fat distribution. Koutsari C, Ali AH, Mundi MS, Jensen MD, Diabetes 60 2032 2040
30. Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Toyoshima Y, Gavrilova O, Yakar S, Jou W, Pack S, Asghar Z, Wheeler MB, LeRoith D, Endocrinology 2005 146 4024 4035 10.1210/en.2005-0087 15947005 (Pubitemid 41175774)
31. Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ, Am J Physiol Endocrinol Metab 2002 283 187 192 12067860
32. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, et al. Nat Med 2002 8 1288 1295 10.1038/nm788 12368907 (Pubitemid 35373562)
33. Adiponectin and adiponectin receptors. Kadowaki T, Yamauchi T, Endocr Rev 2005 26 439 451 10.1210/er.2005-0005 15897298 (Pubitemid 40686653)
34. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Lang CH, Dobrescu C, Bagby GJ, Endocrinology 1992 130 43 52 10.1210/en.130.1.43 1727716
35. The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA. Oliver E, McGillicuddy F, Phillips C, Toomey S, Roche HM, Proc Nutr Soc 69 232 243
36. Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-alpha both in vitro and in vivo systems. Vassiliou EK, Gonzalez A, Garcia C, Tadros JH, Chakraborty G, Toney JH, Lipids Health Dis 2009 8 25 10.1186/1476-511X-8-25 19558671
37. Adipokines and insulin resistance. Rabe K, Lehrke M, Parhofer KG, Broedl UC, Mol Med 2008 14 741 751 19009016
38. Tumour necrosis factor alpha: a key regulator of adipose tissue mass. Warne JP, J Endocrinol 2003 177 351 355 10.1677/joe.0.1770351 12773114 (Pubitemid 36722289)
39. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B, Am J Physiol Endocrinol Metab 2003 285 527 533 12736161
40. Globular adiponectin decreases leptin-induced tumor necrosis factor-alpha expression by murine macrophages: involvement of cAMP-PKA and MAPK pathways. Zhao T, Hou M, Xia M, Wang Q, Zhu H, Xiao Y, Tang Z, Ma J, Ling W, Cell Immunol 2005 238 19 30 10.1016/j.cellimm.2005.12.002 16438946 (Pubitemid 43288029)
41. The role of dietary fat in adipose tissue metabolism. Fernandez-Quintela A, Churruca I, Portillo MP, Public Health Nutr 2007 10 1126 1131 17903320 (Pubitemid 350085200)
42. Sex differences in the regulation of body weight. Shi H, Clegg DJ, Physiol Behav 2009 97 199 204 10.1016/j.physbeh.2009.02.017 19250944
43. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, et al. Mol Cell 1999 4 597 609 10.1016/S1097-2765(00)80210-5 10549291 (Pubitemid 29531139)
44. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Brown JD, Plutzky J, Circulation 2007 115 518 533 10.1161/CIRCULATIONAHA.104.475673 17261671 (Pubitemid 46184203)
45. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Arenare F, Spaziani D, Mancia G, Hypertension 2009 53 205 209 19124679
46. Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. Bidasee KR, Nallani K, Yu Y, Cocklin RR, Zhang Y, Wang M, Dincer UD, Besch HR Jr, Diabetes 2003 52 1825 1836 10.2337/diabetes.52.7.1825 12829653 (Pubitemid 36805580)
47. Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 year decreases plasma C-reactive protein and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program. Carrero JJ, Fonolla J, Marti JL, Jimenez J, Boza JJ, Lopez-Huertas E, J Nutr 2007 137 384 390 17237316 (Pubitemid 46213454)
48. Animal models in type 2 diabetes research: an overview. Srinivasan K, Ramarao P, Indian J Med Res 2007 125 451 472 17496368 (Pubitemid 46805458)